- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/864 - Parvoviral vectors
Patent holdings for IPC class C12N 15/864
Total number of patents in this class: 2051
10-year publication summary
|
42
|
48
|
50
|
101
|
98
|
97
|
111
|
156
|
203
|
141
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4323 |
89 |
| University of Florida Research Foundation, Inc. | 4035 |
64 |
| Research Institute at Nationwide Children's Hospital | 556 |
43 |
| The University of North Carolina at Chapel Hill | 2040 |
32 |
| The Children's Hospital of Philadelphia | 787 |
31 |
| University of Massachusetts | 2225 |
30 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
29 |
| The Regents of the University of California | 19961 |
26 |
| Genethon | 253 |
25 |
| REGENXBIO Inc. | 237 |
25 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
23 |
| Genzyme Corporation | 1262 |
23 |
| Centre National de La Recherche Scientifique | 10464 |
22 |
| Voyager Therapeutics, Inc. | 262 |
22 |
| President and Fellows of Harvard College | 5986 |
20 |
| Universitat Autonoma de Barcelona | 316 |
18 |
| University of Iowa Research Foundation | 823 |
17 |
| The Broad Institute, Inc. | 1827 |
16 |
| Sangamo Therapeutics, Inc. | 416 |
16 |
| Spark Therapeutics, Inc. | 168 |
15 |
| Other owners | 1465 |